Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR1800017742Phase 4Recruiting
Phase 4, randomised, open-label trial of pirfenidone in Urethral stenosis (2 arms), sponsored by Shanghai Sixth People's Hospital. Primary endpoints: Urinary flow rate and Urethrography. Started Aug 2018; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR1800017742.